InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Puromycin | Deregulated JNK signaling enhances apoptosis during hyperthermia. | 2024 | Int J Hyperthermia | Enomoto A. et al. | DOI: 10.1080/02656736.2024.2335199 |
THP1-Dual™ Cells | STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... | 2024 | ACS Appl Bio Mater. | Pastora L.E. et al. | DOI: 10.1021/acsabm.3c01305 |
RAW-Dual™ Cells | STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... | 2024 | ACS Appl Bio Mater. | Pastora L.E. et al. | DOI: 10.1021/acsabm.3c01305 |
LumiKine™ Xpress mIFN-β 2.0 | STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... | 2024 | ACS Appl Bio Mater. | Pastora L.E. et al. | DOI: 10.1021/acsabm.3c01305 |
QUANTI-Luc™: Luciferase Detection Reagent | STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... | 2024 | ACS Appl Bio Mater. | Pastora L.E. et al. | DOI: 10.1021/acsabm.3c01305 |
THP1-Dual™ KO-TREX1 Cells | STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... | 2024 | ACS Appl Bio Mater. | Pastora L.E. et al. | DOI: 10.1021/acsabm.3c01305 |
Blasticidin | miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2. | 2024 | Arch Virol. | Wang S. et al. | DOI: 10.1007/s00705-024-05992-x |
HKCA | Helper T cell immunity in humans with inherited CD4 deficiency. | 2024 | J Exp Med. | Guérin A. et al. | DOI: 10.1084/jem.20231044 |
LPS-SM Ultrapure (LPS from S. minnesota R595) | A serine-conjugated butyrate prodrug with high oral bioavailability suppresse... | 2024 | Nat Biomed Eng. | Cao S. et al. | DOI: 10.1038/s41551-024-01190-x |
Poly(I:C) HMW | Characterization of feline-originated probiotics Lactobacillus rhamnosus CACC... | 2024 | BMC Vet Res. | Jang H.J. et al. | DOI: 10.1186/s12917-024-03975-3 |
Primocin® | Influence of Substrate Stiffness on iPSC-Derived Retinal Pigmented Epithelial... | 2024 | Stem Cells Transl Med. | Wendland R.J. et al. | DOI: 10.1093/stcltm/szae022 |
Blasticidin | Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosph... | 2024 | J Mol Med (Berl). | Campos-Díaz A. et al. | DOI: 10.1007/s00109-024-02442-8 |
Puromycin | Study on the Extrapolability of Current Tumorgenicity Test With Mice by Compa... | 2024 | Stem Cells Transl Med. | Tamura T. et al. | DOI: 10.1093/stcltm/szae019 |
Pam3CSK4 VacciGrade™ | Metabolic trade-offs in Neonatal sepsis triggered by TLR4 and TLR1/2 ligands ... | 2024 | Brain Behav Immun. | Joana Alves M. et al. | DOI: 10.1016/j.bbi.2024.03.027 |
Puromycin | DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancer... | 2024 | Cancer Immunol Immunother. | Ma Z. et al. | DOI: 10.1007/s00262-024-03673-x |
Puromycin | Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastr... | 2024 | Cancer Med. | Wirsik N.M. et al. | DOI: 10.1002/cam4.6866 |
Recombinant anti-mouse CD20 antibody | Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogeni... | 2024 | Hepatology | Feng X. et al. | DOI: 10.1097/HEP.0000000000000831 |
Primocin® | Protocol for generating mouse morula-like cells resembling 8- to 16-cell stag... | 2024 | STAR Protoc. | Li H. et al. | DOI: 10.1016/j.xpro.2024.102934 |
LPS-EK (LPS from E. coli K12) | Clinical validation of circulating GDF15/MIC-1 as a marker of response to doc... | 2024 | Prostate | Mahon K.L. et al. | DOI: 10.1002/pros.24691 |
Alhydrogel® adjuvant 2% | Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral... | 2024 | Emerg Microbes Infect. | Wang T. et al. | DOI: 10.1080/22221751.2024.2337665 |